Reference
NICE. Cost of cystic fibrosis treatment too high for benefit offered, says NICE. Media Release : 17 Jun 2016. Available from: URL: http://www.nice.org.uk
Rights and permissions
About this article
Cite this article
UK NICE says no to lumacaftor-ivacaftor for CF. PharmacoEcon Outcomes News 756, 40 (2016). https://doi.org/10.1007/s40274-016-3189-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3189-8